{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:00:25Z","timestamp":1772082025602,"version":"3.50.1"},"reference-count":47,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>At present, the horse or human rabies immunoglobulin (RIG) used for postexposure prevention of human rabies (PEP) has high cost and limited availability. It is strongly encouraged to replace RIG with equivalent or more effective and safer products. Mouse and human monoclonal antibodies have been shown to protect rodents from lethal rabies virus (RABV) attacks. In this study, we reported a human\u2013mouse chimeric monoclonal antibody, 12\u20102A12, which showed a strong neutralization potency and a wide breadth against multiple street viruses of RABV in vitro. The antibody binded the viral glycoprotein (G) with nanomolar affinity. The complex structure of 12\u20102A12 bound to RABV G revealed that the antibody recognizes an epitope that partially overlaps with the recognition region for the nicotinic acetylcholine receptor (nAChR). The antibody therefore would interfere with the nAChR\/G interaction to block the viral receptor binding. In addition, comparison of our complex structure with the G structure in the acidic state reveals a clear steric clash, highlighting that the antibody would further prevent the conformational changes of the viral glycoprotein that are essential for membrane fusion. In light of these functional and structural data, we believe that 12\u20102A12 might be developed to be included in an antibody cocktail for potential use in human rabies PEP.<\/jats:p>","DOI":"10.1002\/jmv.28954","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T11:24:25Z","timestamp":1690370665000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Characterization of a human\u2013mouse chimeric monoclonal antibody targeting rabies virus glycoprotein"],"prefix":"10.1002","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0765-2957","authenticated-orcid":false,"given":"Meina","family":"Cai","sequence":"first","affiliation":[{"name":"Division of HIV\/AIDS and Sex\u2010Transmitted Virus Vaccines Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5849-6382","authenticated-orcid":false,"given":"Ziliang","family":"Hu","sequence":"additional","affiliation":[{"name":"Institutes of Physical Science and Information Technology Anhui University Hefei China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[{"name":"Biocytogen Pharmaceuticals (Beijing) Co., Ltd Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Mao","sequence":"additional","affiliation":[{"name":"Biocytogen Pharmaceuticals (Beijing) Co., Ltd Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yacui","family":"Liu","sequence":"additional","affiliation":[{"name":"Biocytogen Pharmaceuticals (Beijing) Co., Ltd Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangwen","family":"Lu","sequence":"additional","affiliation":[{"name":"West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy and Cancer Center, West China Hospital Sichuan University, Collaborative Innovation Center of Biotherapy Chengdu China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1873-1085","authenticated-orcid":false,"given":"Fanli","family":"Yang","sequence":"additional","affiliation":[{"name":"West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy and Cancer Center, West China Hospital Sichuan University, Collaborative Innovation Center of Biotherapy Chengdu China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxun","family":"Qi","sequence":"additional","affiliation":[{"name":"Savaid Medical School University of Chinese Academy of Sciences Beijing China"},{"name":"CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology Chinese Academy of Sciences Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijin","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS and Sex\u2010Transmitted Virus Vaccines Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9769-5141","authenticated-orcid":false,"given":"Youchun","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS and Sex\u2010Transmitted Virus Vaccines Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp042140"},{"issue":"10","key":"e_1_2_9_3_1","first-page":"1182","article-title":"Overview, prevention, and treatment of rabies","volume":"29","author":"Daniel GH","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12250-012-3265-6"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-387040-7.00001-9"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/v8110279"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/294275a0"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2018.11"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.91"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.4142\/jvs.2011.12.1.57"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(88)90125-3"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.102.3.716"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9861(19990428)407:1<77::AID-CNE6>3.0.CO;2-S"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-1702(85)90014-0"},{"key":"e_1_2_9_15_1","unstructured":"RabiesW.WHO expert consultation on rabies: first report.WHO Expert Consultation on Rabies: first report 2005."},{"issue":"4","key":"e_1_2_9_16_1","first-page":"315","article-title":"Is the acetylcholine receptor a rabies\u2010virus receptor?","volume":"56","author":"Wunner WH","year":"1982","journal-title":"Trends Neurosci"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/prot.340020406"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00109a020"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.300030205"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2020.03.012"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.10.009"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201605563"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature05901"},{"key":"e_1_2_9_24_1","first-page":"477","article-title":"Postexposure treatment of rabies infection: can it be done without immunoglobulin?","volume":"4","author":"Henry W","year":"2002","journal-title":"Clin Infect Dis"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2.3.399"},{"key":"e_1_2_9_26_1","first-page":"95","article-title":"Can rabies be eradicated?","volume":"131","author":"Rupprecht CE","year":"2008","journal-title":"Dev Biol (Basel)"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s100960050269"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(89)90010-8"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.2.228"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00792-14"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.67.3.1365-1372.1993"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.9.5528-5534.1995"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-385891-7.00003-9"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu085"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201505986"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000542"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159313"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-80-10-2545"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2006.02.007"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-1702(03)00217-X"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2005.01.023"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2078742"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2019.12.012"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(97)76066-X"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444901012471"},{"issue":"10","key":"e_1_2_9_46_1","first-page":"1373","article-title":"Coot: model\u2010building tools for molecular graphics","volume":"57","author":"Emsley P","year":"2001","journal-title":"Acta Crystallogr D"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444909052925"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/pro.3330"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.28954","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T09:24:11Z","timestamp":1696411451000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.28954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1002\/jmv.28954"],"URL":"https:\/\/doi.org\/10.1002\/jmv.28954","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"2023-04-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e28954"}}